TCI GENE Inc. (TPEX:6879)
Taiwan
· Delayed Price · Currency is TWD 33.25
-0.05 (-0.15%)
Mar 10, 2026, 1:34 PM CST
TCI GENE Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 35.8 | 56.31 | 11.67 | 72.15 | 92.45 | 35.75 |
| Depreciation & Amortization | 12.41 | 13.16 | 15.05 | 29.29 | 37.36 | 7.3 |
| Other Amortization | 0.56 | 0.64 | 0.89 | 0.36 | 0.48 | 0.15 |
| Loss (Gain) From Sale of Assets | -7.09 | -7.03 | - | -0.24 | -0.01 | - |
| Loss (Gain) From Sale of Investments | 44.34 | 20.15 | - | - | - | - |
| Loss (Gain) on Equity Investments | 10.3 | 9.35 | 5.86 | 3.45 | - | - |
| Stock-Based Compensation | - | - | - | - | 7.26 | - |
| Provision & Write-off of Bad Debts | -0.87 | 3.27 | 0.09 | 0.53 | 0.32 | - |
| Other Operating Activities | -5.08 | 1.84 | -4.84 | 0.95 | 15.79 | 9.4 |
| Change in Accounts Receivable | -3.67 | 3.66 | -31.05 | 44.73 | -72.48 | -11.76 |
| Change in Inventory | 25.94 | 10.98 | 2.18 | -25.79 | -1.2 | -21.71 |
| Change in Accounts Payable | -7.3 | -35.56 | 15.46 | -11.41 | 18.31 | 29.15 |
| Change in Unearned Revenue | -1.9 | -1.51 | -0.33 | -5.5 | -0.96 | 7.31 |
| Change in Other Net Operating Assets | -6.29 | -18.31 | 2.87 | 1.84 | 21.86 | -0.93 |
| Operating Cash Flow | 97.15 | 56.97 | 17.85 | 110.35 | 119.18 | 54.64 |
| Operating Cash Flow Growth | - | 219.16% | -83.83% | -7.41% | 118.14% | - |
| Capital Expenditures | -2.61 | -2.57 | -2.39 | -13.95 | -22.79 | -22.82 |
| Sale of Property, Plant & Equipment | 8.13 | 8.05 | - | 0.79 | 0.9 | - |
| Sale (Purchase) of Intangibles | -0.09 | -0.09 | -0.78 | -1.34 | -0.63 | -0.09 |
| Investment in Securities | -44.84 | -629.89 | -198.6 | -25 | -5.23 | -0.5 |
| Other Investing Activities | 3.25 | 5.16 | -2.1 | -0.49 | 0.81 | -5.51 |
| Investing Cash Flow | -36.17 | -619.34 | -203.86 | -40 | -26.95 | -28.93 |
| Long-Term Debt Repaid | - | -6.71 | -6.71 | -8.72 | -5.33 | - |
| Net Debt Issued (Repaid) | -3.35 | -6.71 | -6.71 | -8.72 | -5.33 | - |
| Issuance of Common Stock | - | - | 8.98 | 598.1 | 59.94 | - |
| Common Dividends Paid | -26.46 | -26.46 | -52.92 | -53.65 | - | - |
| Other Financing Activities | -2.36 | -2.36 | - | - | - | - |
| Financing Cash Flow | -32.17 | -35.52 | -50.64 | 535.73 | 54.61 | - |
| Foreign Exchange Rate Adjustments | -0.81 | 0.28 | -0.04 | 0.47 | 1.78 | 0.11 |
| Net Cash Flow | 28 | -597.62 | -236.69 | 606.55 | 148.62 | 25.81 |
| Free Cash Flow | 94.55 | 54.4 | 15.46 | 96.4 | 96.39 | 31.81 |
| Free Cash Flow Growth | - | 251.78% | -83.96% | 0.01% | 203.00% | - |
| Free Cash Flow Margin | 29.12% | 15.65% | 4.63% | 22.73% | 22.30% | 16.49% |
| Free Cash Flow Per Share | 3.56 | 2.05 | 0.58 | 3.92 | 4.87 | 1.70 |
| Cash Interest Paid | - | - | - | 0.1 | - | - |
| Cash Income Tax Paid | 12.17 | 9.9 | 3.06 | 17.78 | 9.03 | 2.82 |
| Levered Free Cash Flow | 72.52 | 7.31 | -6.98 | 64.93 | 80.59 | - |
| Unlevered Free Cash Flow | 73.06 | 7.62 | -6.24 | 65.47 | 81.11 | - |
| Change in Working Capital | 6.78 | -40.73 | -10.87 | 3.86 | -34.46 | 2.05 |
Source: S&P Capital IQ. Standard template. Financial Sources.